Charles River Laboratories International, Inc. is an American contract research company headquartered in Wilmington, Massachusetts, a major supplier of research models and preclinical drug development and safety testing services to the pharmaceutical and biotechnology industries. It was founded in 1947 by Henry Foster, initially to breed laboratory rodents of consistent genetic and health quality for use in biomedical research, taking its name from the Charles River near its original Massachusetts facility. Charles River expanded well beyond its original rodent-breeding business into a broad range of outsourced early-stage drug development services, including toxicology and safety testing, and it remains a leading supplier of the specialized research models still used across the industry.
Facts
Company Type Founded Year Company Type
Company Type (category) Connections
Operates In
Source Wikipedia: Charles River Laboratories
Source Wikipedia: Charles River Laboratories
Source Wikipedia: Charles River Laboratories
In the Other Atlases
Located In
Also in Geography Atlas: where this subject is located.
Sources
1. Wikipedia: Charles River Laboratories
WikipediaInfobox: type
Public
Lead section
Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics.
Operates In: Pharmaceutical Industry, Infobox: industry
Pharmaceuticals, Biotechnology, Gene therapy, Cell therapy, Medical devices, Contract research organization, Contract research
Operates In: Biotechnology Industry, Infobox: industry
Pharmaceuticals, Biotechnology, Gene therapy, Cell therapy, Medical devices, Contract research organization, Contract research
Operates In: Medical Device Industry, Infobox: industry
Pharmaceuticals, Biotechnology, Gene therapy, Cell therapy, Medical devices, Contract research organization, Contract research
View the Source Wikidata: Charles River Laboratories International, Inc.
Wikidata Q5082076, class allow-list match (w-wdresolver-0926)View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.